Foresite Capital Management II as of Sept. 30, 2015
Portfolio Holdings for Foresite Capital Management II
Foresite Capital Management II holds 22 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aimmune Therapeutics | 31.4 | $104M | 4.1M | 25.32 | |
| Aduro Biotech | 12.4 | $41M | 2.1M | 19.37 | |
| Zafgen | 7.9 | $26M | 811k | 31.95 | |
| Adaptimmune Therapeutics (ADAP) | 6.4 | $21M | 1.8M | 11.97 | |
| Universal American | 5.8 | $19M | 2.8M | 6.84 | |
| Aerie Pharmaceuticals | 4.9 | $16M | 906k | 17.74 | |
| Epizyme | 4.5 | $15M | 1.2M | 12.86 | |
| Regulus Therapeutics | 4.5 | $15M | 2.3M | 6.54 | |
| Alder Biopharmaceuticals | 3.4 | $11M | 345k | 32.76 | |
| Orexigen Therapeutics | 2.8 | $9.1M | 4.3M | 2.11 | |
| Ardelyx | 2.7 | $8.9M | 517k | 17.28 | |
| BioDelivery Sciences International | 2.5 | $8.3M | 1.5M | 5.56 | |
| Nanostring Technologies (NSTGQ) | 2.3 | $7.4M | 465k | 16.00 | |
| Anacor Pharmaceuticals | 2.2 | $7.3M | 62k | 117.71 | |
| Acceleron Pharma | 1.5 | $4.9M | 199k | 24.90 | |
| Quotient | 1.1 | $3.8M | 291k | 13.00 | |
| Regenxbio Inc equity us cm (RGNX) | 1.1 | $3.5M | 157k | 22.03 | |
| Nexvet Biopharma Pub Ltd Co ord | 0.8 | $2.6M | 708k | 3.64 | |
| Scynexis | 0.8 | $2.5M | 337k | 7.28 | |
| Neuroderm Ltd F | 0.5 | $1.6M | 77k | 20.66 | |
| Biotie Therapies Corp. ads | 0.3 | $1.1M | 81k | 13.09 | |
| Axovant Sciences | 0.2 | $840k | 65k | 12.92 |
